• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Special Transfusion Situations

Neutralizing Antibodies to SARS-CoV-2 Persist for at Least 5 Months

Since December 2019, SARS-CoV-2 has infected over 46 million individuals worldwide leading to over 1 million deaths.  While the majority…

November 3, 2020

Cochrane Living Systematic Review: More Data Needed to Determine Efficacy of COVID-19 Convalescent Plasma

Researchers from the Cochrane Library are performing monthly systematic reviews to evaluate the current data on the effectiveness of COVID-19…

October 28, 2020

Meta-Analysis Examines Leukapheresis in Patients with Acute Myeloid Leukemia and Hyperleukocytosis

Hyperleukocytosis (a white blood cell count greater than 100 X 109/L) is a medical emergency with a mortality rate up…

October 14, 2020

COVID-19 Convalescent Plasma Provides More than Neutralizing Antibodies

With few drugs to combat SARS-CoV-2 infections and the approval from the U.S. FDA for Emergency Use Authorization of COVID-19…

September 30, 2020

Positive Coombs Tests and RBC Transfusions in Patients with COVID-19

During the early outbreak of SARS-CoV-2 in Italy, medical doctors and researchers observed a high frequency of positive direct antiglobulin…

August 12, 2020

Studies Find Variable Anti-SARS-CoV-2 Antibody Responses

Three recent studies have analyzed anti-SARS-CoV-2 antibodies among individuals with asymptomatic and mild SARS-CoV-2 infections, and they have found that…

July 29, 2020

mRNA-1273 Vaccine Safe and Induces anti-SARS-CoV-2 Immune Responses

Using prior knowledge of the importance of the coronavirus spike proteins in pathogenesis and immunity as well as the SARS-CoV-2…

July 22, 2020

Practical Guidance for Blood Supply and Use during the COVID-19 Pandemic

Researchers in Europe and Canada reviewed more than 9,000 publications about COVID-19 and identified 414 papers relevant to blood collections,…

July 15, 2020

Therapeutic Plasma Exchange in Patients with Severe COVID-19

Many patients with severe COVID-19 deteriorate rapidly when their immune systems become hyperactive, also known as cytokine storm.  No effective…

July 1, 2020

ABO Blood Group Associated with COVID-19 Severity

It has long been known that different blood antigens may carry risks or protection depending on the disease, and coronaviruses…

June 23, 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Interim pages omitted …
  • Page 14
  • Go to Next Page »

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley